U.S. Involvement In International IVD Standards Development Lags Europe
This article was originally published in The Gray Sheet
Increased involvement by U.S. in vitro diagnostic manufacturers in international standards development would help avert adoption of additional "vertical" device-specific standards, according to Powers Consulting Services President Donald Powers, PhD.
You may also be interested in...
A decision by the French government to implement its previously announced plan to remove from the market certain self-testing in vitro diagnostic blood glucose monitors apparently will not affect the offerings of Johnson & Johnson subsidiary LifeScan.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.